Artelo Biosciences, INC. (ARTL) — S-1 Filings
All S-1 filings from Artelo Biosciences, INC.. Browse 2 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (2)
-
Artelo Registers 4.27M Shares for Resale; Eyes $50M from Equity Deal
— Mar 24, 2026 Risk: high
Artelo Biosciences, Inc. (ARTL) is a clinical-stage biopharmaceutical company focused on lipid-signaling modulation pathways. The company is not selling any sec -
Artelo Files S-1 for Resale of 899,972 Shares; Cancer Drug Shows Promise
— Nov 17, 2025 Risk: high
Artelo Biosciences, Inc. (ARTL) is a clinical-stage biopharmaceutical company focused on lipid-signaling modulation pathways. The company is offering to resell
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX